These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 11398004

  • 1. [Borderline tumors of the ovary: a multicenter study in 137 patients].
    Bonnamy L, Fignon A, Fetissof F, Berger C, Body G, Lansac J.
    J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):272-81. PubMed ID: 11398004
    [Abstract] [Full Text] [Related]

  • 2. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG, Gershenson DM, Malpica A, Deavers M.
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [Abstract] [Full Text] [Related]

  • 3. Conservative treatment of borderline ovarian tumors.
    Tazelaar HD, Bostwick DG, Ballon SC, Hendrickson MR, Kempson RL.
    Obstet Gynecol; 1985 Sep; 66(3):417-22. PubMed ID: 4022501
    [Abstract] [Full Text] [Related]

  • 4. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Chiesa AG, Deavers MT, Veras E, Silva EG, Gershenson D, Malpica A.
    Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
    [Abstract] [Full Text] [Related]

  • 5. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
    Cao DY, Shen K, Tao T, Yang JX, Xiang Y, Huang HF, Wu M, Pan LY, Lang JH.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
    [Abstract] [Full Text] [Related]

  • 6. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
    Laurent I, Uzan C, Gouy S, Pautier P, Duvillard P, Morice P.
    Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
    [Abstract] [Full Text] [Related]

  • 7. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
    Iervolino P, Palmieri M, Rotondi M, D'Alessandro P, Iuliano R.
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
    [Abstract] [Full Text] [Related]

  • 8. Borderline tumors of the ovary.
    Damak T, Ben Hassouna J, Chargui R, Gamoudi A, Hechiche M, Dhieb T, Rahal K.
    Tunis Med; 2014 Jun; 92(6):411-6. PubMed ID: 25741843
    [Abstract] [Full Text] [Related]

  • 9. Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland.
    Kumpulainen S, Kuoppala T, Leminen A, Komulainen M, Puistola U, Sankila R, Mäkinen J, Grénman S.
    Acta Obstet Gynecol Scand; 2007 Jun; 86(5):610-4. PubMed ID: 17464592
    [Abstract] [Full Text] [Related]

  • 10. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
    Mecke H, Börner-Klaussner B, Grosse G, Nadjari B, Hauptmann S.
    Zentralbl Gynakol; 2000 Jun; 122(5):274-9. PubMed ID: 10857214
    [Abstract] [Full Text] [Related]

  • 11. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
    Gotlieb WH, Flikker S, Davidson B, Korach Y, Kopolovic J, Ben-Baruch G.
    Cancer; 1998 Jan 01; 82(1):141-6. PubMed ID: 9428490
    [Abstract] [Full Text] [Related]

  • 12. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
    Marcickiewicz J, Brännström M.
    Acta Obstet Gynecol Scand; 2006 Jan 01; 85(12):1496-500. PubMed ID: 17260228
    [Abstract] [Full Text] [Related]

  • 13. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E, Deavers MT, Silva EG, Malpica A.
    Am J Surg Pathol; 2007 May 01; 31(5):774-82. PubMed ID: 17460463
    [Abstract] [Full Text] [Related]

  • 14. Recurrence after cystectomy for borderline ovarian tumors: results of a French multicenter study.
    Poncelet C, Fauvet R, Boccara J, Daraï E.
    Ann Surg Oncol; 2006 Apr 01; 13(4):565-71. PubMed ID: 16491337
    [Abstract] [Full Text] [Related]

  • 15. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
    Fauvet R, Boccara J, Dufournet C, David-Montefiore E, Poncelet C, Daraï E.
    Cancer; 2004 Mar 15; 100(6):1145-51. PubMed ID: 15022280
    [Abstract] [Full Text] [Related]

  • 16. [Our experience in treating ovarian tumors with borderline malignancy].
    Ivanov S, Kŭrlov T, Ivanov S.
    Akush Ginekol (Sofiia); 2000 Mar 15; 39(1):39-41. PubMed ID: 10826337
    [Abstract] [Full Text] [Related]

  • 17. [Ovarian low malignant potential tumor: how to preserve fertility?].
    Koskas M, Madelenat P, Yazbeck C.
    Gynecol Obstet Fertil; 2009 Mar 15; 37(11-12):942-50. PubMed ID: 19819742
    [Abstract] [Full Text] [Related]

  • 18. Ovarian epithelial tumors of low malignant potential: a case series of 5 adolescent patients.
    Aggarwal A, Lucco KL, Lacy J, Kives S, Gerstle JT, Allen L.
    J Pediatr Surg; 2009 Oct 15; 44(10):2023-7. PubMed ID: 19853767
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.
    Kane A, Uzan C, Rey A, Gouy S, Camatte S, Pautier P, Lhommé C, Haie-Meder C, Duvillard P, Morice P.
    Oncologist; 2009 Jun 15; 14(6):591-600. PubMed ID: 19487334
    [Abstract] [Full Text] [Related]

  • 20. Management of borderline tumors of the ovary: state of the art.
    Tropé C, Kaern J.
    Semin Oncol; 1998 Jun 15; 25(3):372-80. PubMed ID: 9633850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.